D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
ORMP holding history
Oramed Pharmaceuticals Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ORMP overviewAll 13F holders of ORMPFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −38,566−100.0% | Sold out | Holders |
| Q2 2024 | 38,566 | $99.1K | <0.1% | −31,936−45.3% | Reduced | Holders |
| Q1 2024 | 70,502 | $205.9K | <0.1% | +11,432+19.4% | Added | Holders |
| Q4 2023 | 59,070 | $136.5K | <0.1% | +59,070 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −13,744−100.0% | Sold out | Holders |
| Q1 2022 | 13,744 | $119.0K | <0.1% | −161,051−92.1% | Reduced | Holders |
| Q4 2021 | 174,795 | $2.50M | <0.1% | +174,795 | New | Holders |